4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-056248
Options or other derivatives
- Chief Legal Officer acquired 135,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DiFabio Andrea · Chief Legal Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-07 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +135,000 | 135,000 | D |
Loading xslF345X03/doc4.xml…